300x VivaDiag ™ SARS-CoV-2 Ag rapid test

Code: 2981
1 rating
Brand: VivaDiag
€320,60
In stock with partner
Delivery to:
29/04/2024

The VivaDiagTM SARS-CoV-2 Ag rapid test is used for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV 2 in human nasal, oropharyngeal or nasopharyngeal swab samples. The test is only intended for in vitro diagnostics. For professional use only. It is intended for clinical laboratories and healthcare professionals as a point-of-care test. Not for personal use.

Detailed information

Product detailed description

The VivaDiag ™ SARS-CoV-2 Ag rapid test is based on immunoassay technology. Each test card has anti-SARS-CoV-2 monoclonal antibodies on the detection line (T line) and anti-mouse IgG polyclonal antibodies on the control line (C line). When the extracted sample is added to the sample well, it reacts with the labeled antibody to form a complex, the mixture then migrates through the membrane by capillary action and interacts with the coated anti-SARS-CoV-2 monoclonal antibody on the T-line. If the sample contains SARS-CoV-2-Ag, the T-line will appear purple, indicating that the SARS-CoV-2 Ag is positive. Otherwise the test result is negative. The test card also contains a control line C, which should appear purple for all valid tests. If the C-line does not appear, the test result is invalid even if the T-line is displayed.

Features of the test:

  • Easy to use
  • Diagnostic sensitivity (SARS-CoV-2): 90.90 percent.
  • Diagnostic specificity (SARS-CoV-2): 100 percent.
  • Storage at room temperature (2-30 ?)
  • Quick result in just 15 minutes.
  • BfArM listed.
  • Can also be used by untrained people.
  • Number of pcs: 300 pcs

Additional parameters

Category: COVID Tests
Warranty: 2 years